CUA Educational Content

Maintaining Quality of Life in Patients Undergoing Androgen Deprivation Therapy Across the Continuum of Prostate Cancer

EDITORIAL COMMITTEE: Liette Connor, Sophie Ménard, Devin Pugsley

By participating in this program, health care providers can expect to:

  • Review the continuum of care for patients with prostate cancer undergoing androgen deprivation therapy (ADT) 
  • Explain the importance of achieving castrate levels of testosterone (T) in men with prostate cancer
  • Describe the practical management of secondary side effects associated with ADT

 

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit

​This program was made possible with financial support from Tolmar.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy